Human BioSciences, Inc.

 

BioCore.com - BioCore,Medifil,Skintemp,Collagen,Kollagen

"Our Center has achieved a greater than 95% timely wound closure rate utilizing Kollagen in our treatment protocols.”

Charles R. Baxter, MD Charles R. Baxter Wound Center Dallas, Texas

BioCore.com - BioCore,Medifil,Skintemp,Collagen,Kollagen

BioCore.com - BioCore,Medifil,Skintemp,Collagen,Kollagen

BioCore.com - BioCore,Medifil,Skintemp,Collagen,Kollagen

BioCore.com - BioCore,Medifil,Skintemp,Collagen,Kollagen

 

Research & Developments

  • Drug Delivery

By manipulating the collagen electrical properties and secondarily by regulating the collagen degradation rate, Human BioSciences has developed "smart technology" that will overcome existing challenges and provide additional benefits.  This "smart technology" combines medical, electronic/computer and communications technologies to provide clinicians with an assessment, delivery and compliance tool. 

This approach has four key benefits: ability to

  1. establish patient specific dosing

  2. obtain feedback data from collagen delivery patch if necessary from a remote location

  3. adjust dosing parameters based on the feedback data

  4. measure compliance.  Examples of potential utilization include controlling hypertension, smoking cessation, eating disorders, treatment of emotional and mental illnesses, diabetes etc.

Preliminary effectiveness testing has already been done.

 

 

 

 

 

 

 

Designed and Hosted by ART WEBSITE HOSTING - www.webdesigndoor.com         Home | Contact Us | Careers | Sitemap |©2009 Human BioSciences, Inc.